Pharmacokinetics of Amlodipine and Olmesartan After Administration of Amlodipine Besylate and Olmesartan Medoxomil in Separate Dosage Forms and as a Fixed-Dose Combination
- 1 November 2008
- journal article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 48 (11) , 1309-1322
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Risk of cardiovascular events among women with high normal blood pressure or blood pressure progression: prospective cohort studyBMJ, 2007
- Fixed-Dose Combination Antihypertensives and Reduction in Target Organ DamageAmerican Journal of Cardiovascular Drugs, 2007
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension, 2003
- Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studiesThe Lancet, 2002
- Olmesartan MedoxomilDrugs, 2002
- Impact of High-Normal Blood Pressure on the Risk of Cardiovascular DiseaseNew England Journal of Medicine, 2001
- When Antihypertensive Monotherapy FailsSouthern Medical Journal, 2000
- Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trialThe Lancet, 1998
- Clinical Pharmacokinetics of AmlodipineClinical Pharmacokinetics, 1992
- Amlodipine Pharmacokinetics in Healthy VolunteersThe Journal of Clinical Pharmacology, 1988